Poly Medicure Ltd - Stock Valuation and Financial Performance

BSE: 531768 | NSE: POLYMED | Medical Equipment/Supplies/Accessories | Small Cap

Poly Medicure Share Price

2,880 82.25 2.94%
as on 31-Oct'24 16:01

DeciZen - make an informed investing decision on Poly Medicure

Overall Rating
Bole Toh

1. Quality

2. Valuation

Overvalued

3. Price Trend

Poly Medicure stock performance -

mw4me loader
P/E Ratio (SA):
99.92
Market Cap:
29,127.1 Cr.
52-wk low:
1,361
52-wk high:
2,880

Is Poly Medicure Ltd an attractive stock to invest in?

1. Is Poly Medicure Ltd a good quality company?

Past 10 year's financial track record analysis by Moneyworks4me indicates that Poly Medicure Ltd is a good quality company.

2. Is Poly Medicure Ltd undervalued or overvalued?

The key valuation ratios of Poly Medicure Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone.

3. Is Poly Medicure Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Strong which suggest that the price of Poly Medicure Ltd is likely to Rise in the short term. However, please check the rating on Quality and Valuation before investing

10 Year X-Ray of Poly Medicure:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Poly Medicure Ltd has performed well in majority of the past ten years indicating its past ten year financial track record is very good

Value Creation

Value Creation Index Colour Code Guide

Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24TTM
ROCE % 39.4%26.1%25.3%26%22.9%24.6%21.6%17.7%19.3%23.3%-
Value Creation
Index
1.80.90.80.90.60.80.60.30.40.7-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 3743944405085876467478791,0681,3071,452
Sales YoY Gr.-5.6%11.4%15.7%15.4%10.1%15.7%17.7%21.5%22.4%-
Adj EPS 555.67.16.99.612.914.317.92528.8
YoY Gr.-0.8%12.4%27.1%-3.1%39.4%34%10.7%25.6%39.6%-
BVPS (₹) 21.825.430.537.94348.699.4112.1128.4151.6254.1
Adj Net
Profit
43.74449.562.960.985124137172240291
Cash Flow from Ops. 63.361.95575.5113127116126197256-
Debt/CF from Ops. 1.21.31.81.71.31.51.10.90.70.6-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales 14.9%17.4%20.5%22.4%
Adj EPS 19.7%29.4%24.7%39.6%
BVPS24.1%28.7%15.1%18.1%
Share Price 30.2% 69.4% 46.3% 105.8%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24TTM
Return on
Equity %
2621.220.120.817.12117.913.514.917.814.2
Op. Profit
Mgn %
22.621.921.423.922.825.128.224.325.326.927.3
Net Profit
Mgn %
11.711.211.312.410.413.216.515.616.118.420.1
Debt to
Equity
0.40.40.40.40.40.40.10.10.10.10
Working Cap
Days
136144146157159173182177173167154
Cash Conv.
Cycle
54677580807878899287112

Recent Performance Summary

Sales growth is growing at healthy rate in last 3 years 20.49%

Net Profit is growing at healthy rate in last 3 years 24.73%

Sales growth is good in last 4 quarters at 21.80%

Return on Equity has declined versus last 3 years average to 14.20%

Latest Financials - Poly Medicure Ltd.

Standalone Consolidated
TTM EPS (₹) 28.8 29.1
TTM Sales (₹ Cr.) 1,452 1,522
BVPS (₹.) 254.1 255.7
Reserves (₹ Cr.) 2,524 2,541
P/BV 11.31 11.24
PE 99.92 98.78
From the Market
52 Week Low / High (₹) 1360.95 / 2880.00
All Time Low / High (₹) 0.50 / 2817.95
Market Cap (₹ Cr.) 29,127
Equity (₹ Cr.) 50.7
Face Value (₹) 5
Industry PE 86.9

Management X-Ray of Poly Medicure:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Event Update

Login/Register to view analysis.

Analyst's Notes

Key Ratios of Poly Medicure

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24
Sales3743944395085876467478791,0681,307
Operating Expenses 289308345387453484537665802956
Manufacturing Costs96100113131143153162200243275
Material Costs103107110121152153197261300364
Employee Cost 60698194110127131150188229
Other Costs 30334141485147547088
Operating Profit 858694122134162210214266352
Operating Profit Margin (%) 22.6%21.9%21.4%23.9%22.8%25.1%28.1%24.3%24.9%26.9%
Other Income 881414161919393658
Interest 101081113201051013
Depreciation 18202328363946535662
Exceptional Items 20000000000
Profit Before Tax 84657696100122173195237335
Tax 23182026342944495883
Profit After Tax 614756706692130146179252
PAT Margin (%) 16.3%12.0%12.8%13.8%11.3%14.3%17.3%16.6%16.8%19.3%
Adjusted EPS (₹)6.95.46.48.07.510.513.515.218.726.2
Dividend Payout Ratio (%)18%28%39%25%27%19%19%16%16%11%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24

Equity and Liabilities

Shareholders Fund 1922242693343794299531,0751,2321,455
Share Capital 22224444444448484848
Reserves 1702022252903353859051,0271,1841,407
Minority Interest0000000000
Debt5861761061271559181112146
Long Term Debt40314879911116031121
Short Term Debt1830282735443150101145
Trade Payables38304143506056787889
Others Liabilities 66616371105128131100173204
Total Liabilities 3543764495556617721,2311,3341,5961,894

Fixed Assets

Gross Block2522883334174615506557649631,255
Accumulated Depreciation91111133161192226270317365424
Net Fixed Assets161177200256269324385447597831
CWIP 10142018192521437871
Investments 666184658385384181221
Inventories5441586974101109150183193
Trade Receivables598195112124120149191221259
Cash Equivalents 202122205322278171137
Others Assets4537476176122154110165183
Total Assets 3543764495556617721,2311,3341,5961,894

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24
Cash Flow From Operating Activity 63625575113127116126197256
PBT 65657696100122173195237335
Adjustment 41252238415045396036
Changes in Working Capital -19-14-25-36-1-10-58-60-42-41
Tax Paid -23-14-18-23-27-36-44-47-58-74
Cash Flow From Investing Activity -57-30-54-87-104-106-434-89-189-237
Capex -48-31-55-81-45-104-93-150-237-269
Net Investments -9-1-2-8-62-7-344574820
Others 12323534012
Cash Flow From Financing Activity -9-31-114-10-22319-40-8-17
Net Proceeds from Shares 000000400000
Net Proceeds from Borrowing 0000000000
Interest Paid -8-8-7-9-12-9-8-4-8-10
Dividend Paid -10-27-13-5-21-420-24-24-29
Others 10419292330-73-122422
Net Cash Flow -2103-1-11-202
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24
Ratios
ROE (%)36.3422.7522.8123.2818.5822.8518.7414.415.5218.74
ROCE (%)39.3726.1425.325.9622.9224.6421.6217.6819.3423.28
Asset Turnover Ratio1.191.11.081.020.970.910.750.690.730.75
PAT to CFO Conversion(x)1.031.320.981.071.711.380.890.861.11.02
Working Capital Days
Receivable Days51647274736965707067
Inventory Days45434045444951545752
Payable Days119116117127112131108949584

Poly Medicure Ltd Stock News

Poly Medicure Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of Poly Medicure on 31-Oct-2024 16:01 is ₹2,880.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 31-Oct-2024 16:01 the market cap of Poly Medicure stood at ₹29,127.1.
The latest P/E ratio of Poly Medicure as of 31-Oct-2024 16:01 is 99.92.
The latest P/B ratio of Poly Medicure as of 31-Oct-2024 16:01 is 11.31.
The 52-week high of Poly Medicure is ₹2,880 and the 52-week low is ₹1,361.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Poly Medicure is ₹1,452 ( Cr.) .

About Poly Medicure Ltd

Poly Medicure Ltd. was conceived and established by a group of engineers and technocrats dedicated to the idea of providing the benefits of modern healthcare to the mankind at affordable price. This unique philosophy has been the driving force behind the company since its inception in 1995. Today it has grown into one of the most dynamically versatile manufacturers of disposable healthcare products in the region with over 60 different products.

POLYMED manufactures its products using state of the art technology in ultra modern facilities covering over 300,000 square feet of manufacturing floor space with about 50,000 square feet of clean rooms of class 100,000 to class 1,000. A tool room with modern facilities & CNC machines supports the manufacturing processes. A high degree of automation and an effective process control helps in delivering consistent product quality.

To keep pace with the ever changing requirements of the market, POLYMED has a fully staffed and highly equipped R & D section to design and develop new and innovative products. Using the latest CAD/CAM technology, the new product development is fast and improvements, based on market response and customer feedback, are made with ease. Assuring world class products at affordable prices is the hall mark of POLYMED

Product range of the company:

The company manufactures different products related to :

  • Infusion Therapy
  • Central Venous Access Catheters
  • Anaesthesia
  • Urology
  • Gastroenterology
  • Blood Management
  • Surgery & Wound Drainage
  • Dialysis
  • Others

Achievements/ recognition:

  • QMS (Quality Management System) accredited by SGS
  • ISO 9001:2000
  • ISO-13485:2003
  • CE mark from DNV
  • US FDA 510k approved  
Read More Read Less
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.